Emerging role of miRNAs in the regulation of ferroptosis

Reza Mahmoudi-Lamouki1, Sepideh Kadkhoda2, Bashdar Mahmud Hussen3

  • 1Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

MicroRNAs regulate ferroptosis, a unique cell death pathway crucial in diseases. This review details microRNA involvement in ferroptosis mechanisms and various non-malignant and malignant disorders.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pathology

Background:

  • Ferroptosis is a distinct iron-dependent cell death characterized by lipid ROS accumulation, mitochondrial shrinkage, and cristae reduction.
  • Ferroptosis plays a significant role in the pathogenesis of numerous diseases, making it a key therapeutic target.
  • Emerging research highlights the regulatory role of microRNAs in the ferroptosis pathway.

Purpose of the Study:

  • To review the current understanding of microRNA involvement in ferroptosis.
  • To explore the impact of microRNAs on ferroptosis mechanisms and disease pathology.
  • To summarize the role of specific microRNAs (miR-675, miR-93, miR-27a, miR-34a, miR-141) in ferroptosis.

Main Methods:

  • Literature review of recent studies on microRNAs and ferroptosis.
  • Analysis of microRNA regulation of iron, antioxidant, and lipid metabolism in ferroptosis.
  • Synthesis of findings related to microRNA-mediated ferroptosis in various diseases.

Main Results:

  • MicroRNAs significantly impact ferroptosis by modulating iron, antioxidant, and lipid metabolism.
  • Specific microRNAs (e.g., miR-675, miR-93) have been identified as key regulators of ferroptosis.
  • MicroRNA dysregulation is implicated in the pathology of diverse conditions including cancers, cardiovascular diseases, and neurological disorders.

Conclusions:

  • MicroRNAs are critical regulators of ferroptosis, influencing its core mechanisms.
  • Understanding microRNA-ferroptosis interactions offers potential therapeutic strategies for ferroptosis-associated diseases.
  • This review consolidates knowledge on microRNAs in ferroptosis for both malignant and non-malignant disorders.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.7K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.2K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K